Dual Agonists Under Investigation Tirzepatide (Mounjaro) was approved by the FDA on May 13, 2022 for the treatment of type 2 diabetes in adults, making it the first and only GIP/GLP-1 receptor agonist
In an associated Commentary titled Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward, Juan Brito, MD , from the Mayo Clinic, and coauthors, stated the following: this study stands out for its large scale and robust methodology
Thyroid-stimulating hormone (TSH) can regulate thyroid function, and peptides such as insulin can regulate glucose levels in the body
Watch for: Persistent fatigue or feeling hangry can indicate you are eating too little
PrymaLab provides a Peptide Calculator tool that simplifies dosage calculations for IGF1 LR3 and other research peptides
They work by applying pressure on the P6 or Nei-Kuan acupressure point on each wrist by means of a plastic stud that work to restore balance in the body